10 Followers on Owler

Oisin Biotechnologies

is a biopharmaceutical company that develops therapies for age-related diseases... Read more

Overview Funding Investments News & Insights

Oisin Biotechnologies

is a biopharmaceutical company that develops therapies for age-related diseases... Read more

Co-Founder & CEO

Matthew Scholz

CEO Approval Rating

90/100

2014

SeattleWashington

Seattle Metropolitan Area

Pharmaceuticals & Biotechnology

28368731 NAICS listing

https://www.oisinbio.com/

Est. Annual Revenue

$100K-5.0M

Agree?

Est. Employees

1-25

Agree?

News

Press Release: Oisin Biotechnologies : Oisn Biotechnologies Receives Methuselah Grant to Advance Fat Reduction Study

Press Release: Oisin Biotechnologies : Oisn Biotechnologies Announces Publication of Preclinical Data from its Muscle Building Gene Therapy Program in Cell

OISIN BIOTECHNOLOGIES: Oisï¿½n Biotechnologies : Included in MIT Technology Review's "TR10" List of Top 10 Breakthrough Technologies of 2020

Trending Companies